EU Investigates Gulf Wealth Behind the $110 Billion Paramount and Warner Bros Deal
Brussels, Wednesday 10 June 2026
By 14 July 2026, the EU will determine if Gulf wealth backing Paramount’s $110 billion Warner Bros takeover breaches subsidy rules, setting a critical precedent for foreign investors.
A Dual-Front Regulatory Battlefield
On Tuesday, the United States entertainment conglomerate Paramount Skydance Corp formally sought European Union approval for its $110 billion acquisition of Warner Bros Discovery [1]. The transaction is heavily backed by Gulf sovereign wealth funds, specifically Saudi Arabia’s Public Investment Fund (PIF), the Abu Dhabi-based L’imad Holding Company, and the Qatar Investment Authority (QIA) [1]. Acting as the bloc’s competition enforcer, the European Commission has until 14 July 2026 to either clear the transaction or initiate a comprehensive 90-working-day investigation [1]. This scrutiny is occurring under the Foreign Subsidies Regulation (FSR), a framework designed to neutralise unfair foreign state aid [1].
Overlapping Scrutiny in the Digital Media Era
While the FSR review is critical, the Paramount and Warner Bros consolidation is simultaneously being evaluated under standard EU merger rules [1]. Industry sources suggest that the subsidy review may ultimately prove less arduous than the antitrust assessment, where the merging entities will likely need to offer structural concessions [1]. For example, the companies may be forced to divest assets such as a children’s television channel to alleviate competition concerns [1]. However, FSR remedies are equally potent; the Commission retains the authority to demand the repayment of distortive subsidies, alongside structural divestitures or behavioural commitments such as specific licensing obligations [2].
Broader Implications for Tech and Fintech
The regulatory landscape has become even more stringent with the latest updates published on 9 June 2026, which detail how cross-border transactions face this dual-front regulatory shift [2]. This follows the European Commission’s 30 April 2026 publication of draft revised Merger Guidelines, which consolidated previous horizontal and non-horizontal frameworks into a single system prioritising innovation, supply-chain resilience, and strategic autonomy [2]. These updated guidelines explicitly mandate enhanced scrutiny over ‘killer acquisitions,’ particularly instances where a global incumbent acquires an innovative European biotechnology or technology firm [2]. Such transactions now require comprehensive evidence packages, often including binding commitments to sustain research and development programmes [2].
Navigating the New Deal-Making Reality
For dealmakers and innovation policy officials, the involvement of Middle Eastern sovereign wealth funds in cross-border acquisitions—whether for infrastructure assets or digital media consolidations—frequently triggers these multifaceted screening mechanisms [2]. This necessitates intense coordination between FSR analyses, which scrutinise financial backing, and FDI screenings, which evaluate governance and EU-resident management control [2]. The Paramount-Warner Bros case will serve as a bellwether for how aggressively Brussels intends to police foreign capital [alert! ‘The exact strictness of the impending July 2026 ruling remains uncertain until the Commission publishes its findings’].